143 related articles for article (PubMed ID: 38575803)
1. Long-term endoscopic change of gastric polyp associated with administration of vonoprazan.
Ochiai Y; Ito S; Kikuchi D; Hoteya S
Clin J Gastroenterol; 2024 Apr; ():. PubMed ID: 38575803
[TBL] [Abstract][Full Text] [Related]
2. The effect of proton pump inhibitors and vonoprazan on the development of 'gastric mucosal redness'.
Shinozaki S; Osawa H; Miura Y; Hayashi Y; Sakamoto H; Yano T; Kawarai Lefor A; Yamamoto H
Biomed Rep; 2022 Jun; 16(6):51. PubMed ID: 35620314
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
[TBL] [Abstract][Full Text] [Related]
4. Large Fundic Gland Polyp Associated with Long-Term Proton Pump Inhibitor Administration Mimicking Gastric-Type Neoplasm.
Ochiai Y; Kikuchi D; Ito S; Takazawa Y; Hoteya S
Case Rep Gastroenterol; 2021; 15(1):123-130. PubMed ID: 33708059
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Vonoprazan for Refractory Reflux Esophagitis after Esophagectomy.
Ochiai Y; Iizuka T; Hoshihara Y; Suzuki Y; Hayasaka J; Nomura K; Tanaka M; Odagiri H; Yamashita S; Matsui A; Kikuchi D; Ueno M; Udagawa H; Hoteya S
Dig Dis; 2021; 39(6):569-576. PubMed ID: 33567428
[TBL] [Abstract][Full Text] [Related]
6. The Development of Foveolar-type Gastric Adenocarcinoma during Maintenance Therapy of Vonoprazan for Reflux Esophagitis.
Saito M; Koike T; Abe Y; Nakagawa K; Kanno T; Jin X; Hatta W; Uno K; Asano N; Imatani A; Fujishima F; Masamune A
Intern Med; 2021 Feb; 60(3):391-396. PubMed ID: 32863366
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan.
Hongo M; Fujimoto K;
J Gastroenterol; 2010 Jun; 45(6):618-24. PubMed ID: 20177714
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis.
Hoshino S; Kawami N; Takenouchi N; Umezawa M; Hanada Y; Hoshikawa Y; Kawagoe T; Sano H; Hoshihara Y; Nomura T; Iwakiri K
Digestion; 2017; 95(2):156-161. PubMed ID: 28190016
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Vonoprazan-Treated Patients after Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Multicenter Observation Study.
Ishida T; Dohi O; Yamada S; Yasuda T; Yamada N; Tomie A; Tsuji T; Horii Y; Majima A; Horie R; Fukui A; Zen K; Tomatsuri N; Yagi N; Naito Y; Itoh Y
Digestion; 2021; 102(3):386-396. PubMed ID: 32585678
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration.
Takeda T; Asaoka D; Tajima Y; Matsumoto K; Takeda N; Hiromoto T; Okubo S; Saito H; Aoyama T; Shibuya T; Sakamoto N; Hojo M; Osada T; Nagahara A; Yao T; Watanabe S
Clin J Gastroenterol; 2017 Oct; 10(5):478-484. PubMed ID: 28660530
[TBL] [Abstract][Full Text] [Related]
11. Long-term vonoprazan administration causes gastric fundic gland-type hyperplastic polyps and chronic bleeding.
Goto C; Okimoto K; Matsusaka K; Matsumura T; Akizue N; Ohta Y; Taida T; Saito K; Kato J; Kato N
Clin J Gastroenterol; 2023 Apr; 16(2):159-163. PubMed ID: 36586091
[TBL] [Abstract][Full Text] [Related]
12. Changes of Gastric Juice Microenvironment in Patients with Fundic Gland Polyp and Hyperplastic Polyp.
Gao H; Chang L; Wang L; Zhou X; Wang N
Pathobiology; 2021; 88(6):383-391. PubMed ID: 34500447
[TBL] [Abstract][Full Text] [Related]
13. The Ameliorating Effect of Switching to Vonoprazan: A Novel Potassium-Competitive Acid Blocker in Patients with Proton Pump Inhibitor Refractory Non-Erosive Reflux Disease.
Abe Y; Koike T; Saito M; Okata T; Nakagawa K; Hatta W; Asanuma K; Uno K; Asano N; Imatani A; Masamune A
Digestion; 2021; 102(3):480-488. PubMed ID: 32062650
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of proton pump inhibitor-resistant severe reflux esophagitis and efficacy of vonoprazan in elderly (older than 75 years) and non-elderly groups.
Hoshino S; Momma E; Motomiya R; Tanabe T; Koeda M; Hoshikawa Y; Kawami N; Iwakiri K
JGH Open; 2024 Jan; 8(1):e13023. PubMed ID: 38268954
[TBL] [Abstract][Full Text] [Related]
15. Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Yasugi K; Haruma K; Kawanaka M; Suehiro M; Nakamura J; Urata N; Tanikawa T; Oka T; Monobe Y; Fujita T; Kawamoto H
Case Rep Gastroenterol; 2021; 15(1):202-209. PubMed ID: 33790706
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China.
Wang Z; Sun R; Sheng Y; Qu S; Dong L; Wu B
Ann Transl Med; 2022 Apr; 10(8):480. PubMed ID: 35571388
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report.
Nakashima M; Naoe H; Komohara Y; Waki K; Miyamoto H; Sakai Y; Kojima T; Kanemitsu T; Yao K; Tanaka Y
In Vivo; 2024; 38(3):1465-1469. PubMed ID: 38688629
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Vonoprazan for 48-Week Maintenance Therapy of Patients with Healed Reflux Esophagitis.
Mizuno H; Nishino M; Yamada K; Kamiyamamoto S; Hinoue Y
Digestion; 2020; 101(4):411-421. PubMed ID: 31129668
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics.
Choudhry U; Boyce HW; Coppola D
Am J Clin Pathol; 1998 Nov; 110(5):615-21. PubMed ID: 9802346
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis.
Tanabe T; Hoshino S; Kawami N; Hoshikawa Y; Hanada Y; Takenouchi N; Goto O; Kaise M; Iwakiri K
Esophagus; 2019 Oct; 16(4):377-381. PubMed ID: 31119492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
